Document is current
Any future updates will be listed below
-
Authors
Matsumoto, Tetsuya
Yuasa, Akira https://orcid.org/0000-0002-3699-7231
Matsuda, Hiroyuki
Ainiwaer, Dilinuer
Yonemoto, Naohiro
- License Information
-
More Information
Article History
Received: 21 December 2023
Accepted: 11 March 2024
First Online: 25 April 2024
Declarations
:
: The authors declare the following potential conflicts of interest with respect to the research, authorship and/or publication of this article: Tetsuya Matsumoto has been on the speakers’ bureau for Pfizer Japan Inc., KYORIN Pharmaceutical Co., Ltd., and MSD K.K. Akira Yuasa and Naohiro Yonemoto are full-time employees of Pfizer Japan Inc., and hold stocks and stock options from Pfizer Inc. Hiroyuki Matsuda and Dilinuer Ainiwaer are employees of IQVIA Solutions Japan G.K., which received funding from Pfizer Japan Inc. to undertake the research outlined in this study.
: Ethics approval was not required for this study. This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
